Tharimmune, Inc. (THAR)
NASDAQ: THAR · IEX Real-Time Price · USD
3.190
+0.070 (2.24%)
At close: Jul 26, 2024, 10:27 AM
3.020
-0.170 (-5.33%)
After-hours: Jul 26, 2024, 5:31 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.55 million as of July 26, 2024. Its market cap has decreased by -39.86% in one year.
Market Cap
3.55M
Enterprise Value
-4.56M
1-Year Change
-39.86%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.55M, a decrease of -91.38%. That is a compound annual growth rate of -61.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 2.50M | 525.00% |
| Dec 29, 2023 | 400.00K | -91.11% |
| Dec 30, 2022 | 4.50M | -89.07% |
| Jan 12, 2022 | 41.18M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iSpecimen | 3.73M |
| Sintx Technologies | 3.72M |
| Bio-Path Holdings | 3.69M |
| Onconetix | 3.60M |
| Fresh2 Group | 3.56M |
| Venus Concept | 3.37M |
| Protagenic Therapeutics | 3.28M |
| Avinger | 3.27M |